Literature DB >> 34860253

Immunogenicity of Extended mRNA SARS-CoV-2 Vaccine Dosing Intervals.

Brian Grunau1, David M Goldfarb2, Michael Asamoah-Boaheng3, Liam Golding4, Tracy L Kirkham5, Paul A Demers5, Pascal M Lavoie6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 34860253      PMCID： PMC8642809          DOI： 10.1001/jama.2021.21921

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   157.335


× No keyword cloud information.
  21 in total

1.  Vaccine subtype and dose interval determine immunogenicity of primary series COVID-19 vaccines in older people.

Authors:  Helen Parry; Rachel Bruton; Reni Ayodele; Penny Sylla; Graham McIlroy; Nicola Logan; Sam Scott; Sam Nicol; Kriti Verma; Christine Stephens; Brian Willett; Jianmin Zuo; Paul Moss
Journal:  Cell Rep Med       Date:  2022-08-25

2.  SARS-CoV-2 transmission and impacts of unvaccinated-only screening in populations of mixed vaccination status.

Authors:  Kate M Bubar; Casey E Middleton; Kristen K Bjorkman; Roy Parker; Daniel B Larremore
Journal:  Nat Commun       Date:  2022-05-19       Impact factor: 17.694

3.  Antibody responses and risk factors associated with impaired immunological outcomes following two doses of BNT162b2 COVID-19 vaccination in patients with chronic pulmonary diseases.

Authors:  Zitta Barrella Harboe; Sebastian Rask Hamm; Laura Pérez-Alós; Pradeesh Sivapalan; Helene Priemé; Torgny Wilcke; Peter Kjeldgaard; Saher Shaker; Alexander Svorre Jordan; Dina Leth Møller; Line Dam Heftdal; Johannes Roth Madsen; Rafael Bayarri-Olmos; Cecilie Bo Hansen; Mia Marie Pries-Heje; Rasmus Bo Hasselbalch; Kamille Fogh; Jose Juan Almagro Armenteros; Linda Hilsted; Erik Sørensen; Birgitte Lindegaard; Andrea Browatzki; Tor Biering-Sørensen; Ruth Frikke-Schmidt; Sisse Rye Ostrowski; Kasper Karmark Iversen; Henning Bundgaard; Susanne Dam Nielsen; Peter Garred; Jens-Ulrik Stæhr Jensen
Journal:  BMJ Open Respir Res       Date:  2022-07

4.  Coronavirus Disease 2019 Vaccine Dosage in Children, Adolescents, and Young Adults: Is Less More?

Authors:  Nicole H Tobin; Otto O Yang
Journal:  Open Forum Infect Dis       Date:  2022-05-01       Impact factor: 4.423

5.  Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen.

Authors:  Manon Nayrac; Mathieu Dubé; Gérémy Sannier; Alexandre Nicolas; Lorie Marchitto; Olivier Tastet; Alexandra Tauzin; Nathalie Brassard; Guillaume Beaudoin-Bussières; Dani Vézina; Shang Yu Gong; Mehdi Benlarbi; Romain Gasser; Annemarie Laumaea; Catherine Bourassa; Gabrielle Gendron-Lepage; Halima Medjahed; Guillaume Goyette; Gloria-Gabrielle Ortega-Delgado; Mélanie Laporte; Julia Niessl; Laurie Gokool; Chantal Morrisseau; Pascale Arlotto; Jonathan Richard; Cécile Tremblay; Valérie Martel-Laferrière; Andrés Finzi; Daniel E Kaufmann
Journal:  bioRxiv       Date:  2021-12-21

6.  SARS-CoV-2 Transmission and Impacts of Unvaccinated-Only Screening in Populations of Mixed Vaccination Status.

Authors:  Kate M Bubar; Casey E Middleton; Kristen K Bjorkman; Roy Parker; Daniel B Larremore
Journal:  medRxiv       Date:  2022-03-21

7.  SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between doses.

Authors:  Debashree Chatterjee; Alexandra Tauzin; Lorie Marchitto; Shang Yu Gong; Marianne Boutin; Catherine Bourassa; Guillaume Beaudoin-Bussières; Yuxia Bo; Shilei Ding; Annemarie Laumaea; Dani Vézina; Josée Perreault; Laurie Gokool; Chantal Morrisseau; Pascale Arlotto; Éric Fournier; Aurélie Guilbault; Benjamin Delisle; Inès Levade; Guillaume Goyette; Gabrielle Gendron-Lepage; Halima Medjahed; Gaston De Serres; Cécile Tremblay; Valérie Martel-Laferrière; Daniel E Kaufmann; Renée Bazin; Jérémie Prévost; Sandrine Moreira; Jonathan Richard; Marceline Côté; Andrés Finzi
Journal:  Cell Rep       Date:  2022-02-08       Impact factor: 9.995

8.  SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status.

Authors:  Kiarash Ghazvini; Masoud Keikha
Journal:  Vacunas       Date:  2022-03-09

9.  Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors.

Authors:  Laura Pérez-Alós; Jose Juan Almagro Armenteros; Johannes Roth Madsen; Cecilie Bo Hansen; Ida Jarlhelt; Sebastian Rask Hamm; Line Dam Heftdal; Mia Marie Pries-Heje; Dina Leth Møller; Kamille Fogh; Rasmus Bo Hasselbalch; Anne Rosbjerg; Søren Brunak; Erik Sørensen; Margit Anita Hørup Larsen; Sisse Rye Ostrowski; Ruth Frikke-Schmidt; Rafael Bayarri-Olmos; Linda Maria Hilsted; Kasper Karmark Iversen; Henning Bundgaard; Susanne Dam Nielsen; Peter Garred
Journal:  Nat Commun       Date:  2022-03-28       Impact factor: 14.919

10.  Impaired Neutralizing Antibody Activity against B.1.617.2 (Delta) after Anti-SARS-CoV-2 Vaccination in Patients Receiving Anti-CD20 Therapy.

Authors:  Maximilian Töllner; Claudius Speer; Louise Benning; Marie Bartenschlager; Christian Nusshag; Christian Morath; Martin Zeier; Caner Süsal; Paul Schnitzler; Wilhelm Schmitt; Raoul Bergner; Ralf Bartenschlager; Hanns-Martin Lorenz; Matthias Schaier
Journal:  J Clin Med       Date:  2022-03-21       Impact factor: 4.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.